Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Granulocyte transfusion therapy.

J P Dutcher

    The American Journal of the Medical Sciences
    |March 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Granulocyte transfusion therapy aids in managing serious infections for patients with low granulocyte counts when combined with antibiotics. This approach leverages the inverse relationship between granulocyte levels and infection risk, offering potential clinical benefits.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM<sup>SM</sup> registry.

    Journal for immunotherapy of cancer·2019
    Same author

    A phase I study of cabozantinib (XL184) in patients with renal cell cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Characterization of bone metastases in patients with renal cell cancer.

    BJU international·2004
    Same author

    Accelerated and blastic phase of chronic myeloid leukemia.

    Current treatment options in oncology·2002
    Same author

    Phase I study of recombinant human CD40 ligand in cancer patients.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    Angiogenesis and melanoma.

    Current oncology reports·2001
    Same journal

    Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

    The American journal of the medical sciences·2026
    Same journal

    In Memoriam: Maurice A. Mufson, MD, MACP.

    The American journal of the medical sciences·2026
    Same journal

    Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

    The American journal of the medical sciences·2026
    Same journal

    Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

    The American journal of the medical sciences·2026
    Same journal

    Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

    The American journal of the medical sciences·2026
    Same journal

    The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

    The American journal of the medical sciences·2026
    See all related articles

    Area of Science:

    • Hematology
    • Infectious Diseases
    • Critical Care Medicine

    Background:

    • Granulocytopenia increases infection risk in patients.
    • Granulocyte transfusion therapy is an adjunct to antibiotics for severe infections.
    • Replacement therapy for other blood components (e.g., platelets) is established.

    Purpose of the Study:

    • To evaluate the benefit of granulocyte transfusions in managing serious infections in granulocytopenic patients.
    • To explore the rationale for granulocyte replacement therapy.

    Main Methods:

    • Utilized granulocyte transfusion therapy as an adjunct to broad-spectrum antibiotics.
    • Observed the relationship between absolute granulocyte count and infection incidence.
    • Assessed clinical improvement in relation to granulocyte count increases.

    Related Experiment Videos

    Main Results:

    • Infection incidence is inversely related to absolute granulocyte count.
    • Small increases in granulocyte count correlate with clinical improvement during marrow regeneration.
    • Suggests potential benefit of granulocyte transfusions.

    Conclusions:

    • Granulocyte transfusion therapy is a potentially beneficial adjunct for serious infections in granulocytopenic patients.
    • The rationale is supported by inverse correlation of infection risk with granulocyte counts.
    • Clinical observations suggest efficacy, especially during marrow recovery.